France · Delayed Price · Currency is EUR LNA Santé Statistics
Total Valuation
LNA Santé has a market cap or net worth of EUR 237.05 million. The enterprise value is 1.08 billion.
| Market Cap | 237.05M |
| Enterprise Value | 1.08B |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | Jul 8, 2025 |
Share Statistics
LNA Santé has 10.26 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 10.26M |
| Shares Outstanding | 10.26M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 7.58% |
| Owned by Institutions (%) | 16.90% |
| Float | 6.07M |
Valuation Ratios
The trailing PE ratio is 11.39 and the forward PE ratio is 8.54.
| PE Ratio | 11.39 |
| Forward PE | 8.54 |
| PS Ratio | 0.27 |
| PB Ratio | 0.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.92 |
| P/OCF Ratio | 2.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.84, with an EV/FCF ratio of 13.33.
| EV / Earnings | 52.08 |
| EV / Sales | 1.25 |
| EV / EBITDA | 6.84 |
| EV / EBIT | 15.87 |
| EV / FCF | 13.33 |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 2.75.
| Current Ratio | 0.92 |
| Quick Ratio | 0.44 |
| Debt / Equity | 2.75 |
| Debt / EBITDA | 5.71 |
| Debt / FCF | 11.13 |
| Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is 6.87% and return on invested capital (ROIC) is 3.52%.
| Return on Equity (ROE) | 6.87% |
| Return on Assets (ROA) | 2.73% |
| Return on Invested Capital (ROIC) | 3.52% |
| Return on Capital Employed (ROCE) | 5.91% |
| Revenue Per Employee | 104,253 |
| Profits Per Employee | 2,507 |
| Employee Count | 9,619 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.34 |
Taxes
In the past 12 months, LNA Santé has paid 10.87 million in taxes.
| Income Tax | 10.87M |
| Effective Tax Rate | 32.93% |
Stock Price Statistics
The stock price has decreased by -2.09% in the last 52 weeks. The beta is 0.61, so LNA Santé's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -2.09% |
| 50-Day Moving Average | 24.52 |
| 200-Day Moving Average | 25.60 |
| Relative Strength Index (RSI) | 43.14 |
| Average Volume (20 Days) | 3,210 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LNA Santé had revenue of EUR 863.42 million and earned 20.77 million in profits. Earnings per share was 2.03.
| Revenue | 863.42M |
| Gross Profit | 265.27M |
| Operating Income | 68.03M |
| Pretax Income | 33.00M |
| Net Income | 20.77M |
| EBITDA | 97.16M |
| EBIT | 68.03M |
| Earnings Per Share (EPS) | 2.03 |
Balance Sheet
The company has 68.00 million in cash and 903.01 million in debt, giving a net cash position of -835.01 million or -81.37 per share.
| Cash & Cash Equivalents | 68.00M |
| Total Debt | 903.01M |
| Net Cash | -835.01M |
| Net Cash Per Share | -81.37 |
| Equity (Book Value) | 328.28M |
| Book Value Per Share | 31.08 |
| Working Capital | -33.48M |
Cash Flow
In the last 12 months, operating cash flow was 93.55 million and capital expenditures -12.42 million, giving a free cash flow of 81.13 million.
| Operating Cash Flow | 93.55M |
| Capital Expenditures | -12.42M |
| Free Cash Flow | 81.13M |
| FCF Per Share | 7.91 |
Margins
Gross margin is 30.72%, with operating and profit margins of 7.88% and 2.41%.
| Gross Margin | 30.72% |
| Operating Margin | 7.88% |
| Pretax Margin | 3.82% |
| Profit Margin | 2.41% |
| EBITDA Margin | 11.25% |
| EBIT Margin | 7.88% |
| FCF Margin | 9.40% |
Dividends & Yields
This stock pays an annual dividend of 0.65, which amounts to a dividend yield of 2.81%.
| Dividend Per Share | 0.65 |
| Dividend Yield | 2.81% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 32.06% |
| Buyback Yield | -0.33% |
| Shareholder Yield | 2.49% |
| Earnings Yield | 8.76% |
| FCF Yield | 34.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LNA Santé has an Altman Z-Score of 0.8 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.8 |
| Piotroski F-Score | 6 |